{
    "root": "89518acb-1d44-48cc-aa2e-bcb2022ff0c7",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Travatan Z",
    "value": "20250131",
    "ingredients": [
        {
            "name": "TRAVOPROST",
            "code": "WJ68R08KX9",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_746859"
        },
        {
            "name": "POLYOXYL 40 HYDROGENATED CASTOR OIL",
            "code": "7YC686GQ8F",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_140618"
        },
        {
            "name": "BORIC ACID",
            "code": "R57ZHV85D4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_33118"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01638"
        },
        {
            "name": "ZINC CHLORIDE",
            "code": "86Q357L16B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17996"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        }
    ],
    "indications": {
        "text": "travatan z\u00ae ( travoprost ophthalmic solution ) 0.004 % indicated reduction elevated intraocular pressure ( iop ) patients open-angle glaucoma ocular hypertension .",
        "doid_entities": [
            {
                "text": "open-angle glaucoma (DOID:1067)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1067"
            },
            {
                "text": "glaucoma (DOID:1686)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1686"
            },
            {
                "text": "ocular hypertension (DOID:9282)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9282"
            },
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended one drop affected eye ( ) daily evening . travatan z administered daily since shown frequent prostaglandin analogs may decrease iop-lowering effect . reduction iop starts approximately 2 hours first maximum effect reached 12 hours . travatan z may used concomitantly topical ophthalmic products lower iop . one topical ophthalmic used , drugs administered least 5 minutes apart .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "travatan z sterile , isotonic , buffered , preserved , aqueous solution travoprost ( 0.04 mg/ml ) . travatan z supplied 2.5 ml solution 4 ml 5 ml solution 7.5 ml oval natural polypropylene dispenser bottle natural polypropylene dropper tip turquoise polypropylene high-density polyethylene overcap . 2.5 ml fill\u2026\u2026\u2026\u2026\u2026\u2026\u2026ndc 66758-095-56 5 ml fill\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026ndc 66758-095-75 storage : store 2\u00b0c 25\u00b0c ( 36\u00b0f 77\u00b0f ) . opening , travatan z used expiration date bottle .",
    "adverseReactions": "none .",
    "indications_original": "TRAVATAN Z\u00ae (travoprost ophthalmic solution) 0.004% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.",
    "contraindications_original": "The recommended dosage is one drop in the affected eye(s) once daily in the evening. TRAVATAN Z  should not be administered more than once daily since it has been shown that more frequent administration of prostaglandin analogs may decrease the IOP-lowering effect.\n                  Reduction of the IOP starts approximately 2 hours after the first administration with maximum effect reached after 12 hours.\n                  TRAVATAN Z may be used concomitantly with other topical ophthalmic drug products to lower IOP. If more than one topical ophthalmic drug is being used, the drugs should be administered at least 5 minutes apart.",
    "warningsAndPrecautions_original": "TRAVATAN Z is a sterile, isotonic, buffered, preserved, aqueous solution of travoprost (0.04 mg/mL).\n                  TRAVATAN Z is supplied as a 2.5 mL solution in a 4 mL and a 5 mL solution in a 7.5 mL oval natural polypropylene dispenser bottle with a natural polypropylene dropper tip and a turquoise polypropylene or high-density polyethylene overcap. \n                  2.5 mL fill\u2026\u2026\u2026\u2026\u2026\u2026\u2026NDC 66758-095-56\n                  5 mL fill\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026NDC 66758-095-75\n                  \n                     Storage: Store at 2\u00b0C to 25\u00b0C (36\u00b0F to 77\u00b0F).\n                  After opening, TRAVATAN Z can be used until the expiration date on the bottle.",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "Travatan Z",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_746859"
        }
    ]
}